Publicaciones en colaboración con investigadores/as de University of the Witwatersrand (10)

2023

  1. Blood Composite Scores in Patients with Systemic Lupus Erythematosus

    Biomedicines, Vol. 11, Núm. 10

  2. Relationship between Malondialdehyde Serum Levels and Disease Features in a Full Characterized Series of 284 Patients with Systemic Lupus Erythematosus

    Antioxidants, Vol. 12, Núm. 8

  3. Relationship of Fibroblast Growth Factor 23 Serum Levels with Disease Characteristics in Systemic Lupus Erythematosus Patients

    Biomolecules, Vol. 13, Núm. 8

  4. Serum Levels of Lipoprotein Lipase Are Increased in Patients with Inflammatory Bowel Disease

    International journal of molecular sciences, Vol. 24, Núm. 6

  5. Serum Levels of Transforming Growth Factor Beta 1 in Systemic Lupus Erythematosus Patients

    Biomolecules, Vol. 13, Núm. 1

  6. Transforming growth factor beta 1 is associated with subclinical carotid atherosclerosis in patients with systemic lupus erythematosus

    Arthritis Research and Therapy, Vol. 25, Núm. 1

2022

  1. Apolipoprotein C-III in patients with systemic lupus erythematosus

    Arthritis Research and Therapy, Vol. 24, Núm. 1

  2. Apolipoprotein C-III is linked to the insulin resistance and beta-cell dysfunction that are present in rheumatoid arthritis

    Arthritis Research and Therapy, Vol. 24, Núm. 1

  3. Key Molecules of Triglycerides Pathway Metabolism Are Disturbed in Patients With Systemic Lupus Erythematosus

    Frontiers in Immunology, Vol. 13

  4. Vascular Endothelial Growth Factor and Its Soluble Receptor in Systemic Lupus Erythematosus Patients

    Biomolecules, Vol. 12, Núm. 12